Prof. Ciro Leonardo Pierri's expertise in structural biology, mitochondrial carrier modeling, and drug targeting—demonstrated ...

SL BIO Ltd. ("SL Bio" or the “Company”), a biomedical company specializing in developing innovative cellular and gene therapies, and Horizon Space Acquisition II Corp. (Nasdaq: HSPT) ("HSPT"), a ...

Curi Bio, the leader in delivering human-relevant functional data for drug discovery and development, today announced the ...

The Ghana FDA’s approval was granted following a rigorous, science-based regulatory review that referenced comprehensive data previously evaluated and accepted by the European Medicines Agency (EMA).

Entera Bio Ltd. reported its financial results for Q1 2025, highlighting significant advancements in its development of oral peptide therapies, particularly EB613, an oral anabolic treatment for ...

On July 16, 2025, Bio-Thera Solutions, Ltd. (“Bio-Thera”) announced that the U.S. Food and Drug Administration (“FDA”) had accepted its Biologics License Application (“BLA”) for its golimumab ...

NEW YORK--(BUSINESS WIRE)--Peak Bio Co., Ltd. (“Peak Bio”), a clinical-stage biopharmaceutical company focused on developing the next-generation of therapeutics to treat oncology and inflammatory ...

Karo Bio AB (publ) and Alkem Laboratories Ltd have entered into a collaboration and license agreement regarding eprotirome, currently in late-stage clinical testing for dyslipidemia. Karo Bio will ...

HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: PASW) (hereinafter referred to as “Ping An Bio”) announced that it has ...

GUANGZHOU, China--(BUSINESS WIRE)--Bio-Thera Solutions, Ltd. (688177.SH) today announced the discovery of a broad-spectrum SARS-CoV-2 neutralizing antibody with the potential to treat COVID-19. The ...

SL BIO Ltd. ("SL Bio" or the "Company"), a biomedical company specializing in developing innovative cellular and gene therapies, and Horizon ...